BR9814556A - Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas - Google Patents

Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas

Info

Publication number
BR9814556A
BR9814556A BR9814556-8A BR9814556A BR9814556A BR 9814556 A BR9814556 A BR 9814556A BR 9814556 A BR9814556 A BR 9814556A BR 9814556 A BR9814556 A BR 9814556A
Authority
BR
Brazil
Prior art keywords
staphylococcus aureus
strains isolated
vaccines made
animal
antigenic compositions
Prior art date
Application number
BR9814556-8A
Other languages
English (en)
Inventor
Gabriel Leitner
Eugenia Liubashewsky
Ze Ev Trainin
Original Assignee
Maabarot Products Ltd
Medinath Israel Represented By
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maabarot Products Ltd, Medinath Israel Represented By filed Critical Maabarot Products Ltd
Publication of BR9814556A publication Critical patent/BR9814556A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/445—Staphylococcus aureus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: <B>"CEPAS ISOLADAS DE Staphylococcus aureus E VACINAS FABRICADAS A PARTIR DAS MESMAS"<D>. A presente invenção refere-se a várias cepas de S. aureus BS449, cepas de S.aureus ZO3984 e cepas de S.aureus VLVL 8407 e combinações das mesmas. As cepas acima foram depositadas e registradas em 16 de dezembro de 1997 na CNM Collection Nationale de Cultures de Microorganismes do Institut Pasteur. A invenção também refere-se a uma vacina contra a ocorrência de infecção por mastite bovina que compreende uma combinação das cepas acima de "S. aureus" e à vacinação de vacas contra a ocorrência de infecção por mastite bovina com a dita vacina.
BR9814556-8A 1997-12-31 1998-12-29 Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas BR9814556A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12282997A IL122829A (en) 1997-12-31 1997-12-31 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom
PCT/IL1998/000627 WO1999033954A1 (en) 1997-12-31 1998-12-29 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom

Publications (1)

Publication Number Publication Date
BR9814556A true BR9814556A (pt) 2000-10-17

Family

ID=11071042

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814556-8A BR9814556A (pt) 1997-12-31 1998-12-29 Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas

Country Status (12)

Country Link
US (1) US6544529B1 (pt)
EP (1) EP1042450B1 (pt)
AT (1) ATE318300T1 (pt)
AU (1) AU746285B2 (pt)
BR (1) BR9814556A (pt)
CA (1) CA2317092A1 (pt)
DE (1) DE69833568T2 (pt)
ES (1) ES2259218T3 (pt)
IL (1) IL122829A (pt)
NZ (1) NZ505194A (pt)
PL (1) PL341541A1 (pt)
WO (1) WO1999033954A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974573B2 (en) 1999-11-01 2005-12-13 Mucovax Holdings, B.V. Antibody production in farm animals
US7074454B1 (en) 1999-11-01 2006-07-11 Mucovax Holding B.V. Production of mammary secretion antibodies in farm animals
US8268579B2 (en) * 2008-01-24 2012-09-18 Pilots Point Llc Method and medium for detecting the presence or absence of pathogenic staphylococci in a first generation test sample
EP2844275B1 (en) * 2012-04-26 2020-05-13 University of Chicago Staphylococcal coagulase antigens and methods of their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
AU8592982A (en) * 1981-07-14 1983-01-20 Commonwealth Scientific And Industrial Research Organisation Mastitis vaccine
US4780307A (en) * 1984-10-23 1988-10-25 Rafa Laboratories Ltd. Aluminum hydroxide

Also Published As

Publication number Publication date
ES2259218T3 (es) 2006-09-16
IL122829A (en) 2000-06-29
IL122829A0 (en) 1998-08-16
WO1999033954A1 (en) 1999-07-08
DE69833568T2 (de) 2006-12-28
US6544529B1 (en) 2003-04-08
EP1042450A1 (en) 2000-10-11
AU1681199A (en) 1999-07-19
AU746285B2 (en) 2002-04-18
PL341541A1 (en) 2001-04-23
CA2317092A1 (en) 1999-07-08
ATE318300T1 (de) 2006-03-15
DE69833568D1 (de) 2006-04-27
NZ505194A (en) 2001-12-21
EP1042450B1 (en) 2006-02-22

Similar Documents

Publication Publication Date Title
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
PL304419A1 (en) Urease based vaccine against heliobacter infections
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
BRPI0007936B8 (pt) composto, formulação adjuvante imunológica, e formulação de vacina.
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
DK398683A (da) Fremgangsmaade til fremstilling af antistoffer
BR9814556A (pt) Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
ATE285791T1 (de) Impfstoff, der acemannan als adjuvans enthält
SU1538305A1 (ru) Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
Johns et al. Bovine vibriosis vaccination: immunity conferred by a single biotype
ATE103817T1 (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobulin-g-haeltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen.
AU2579600A (en) Product and method for obtaining specific immunisation with one or more antigens
RU96119161A (ru) Ассоциированная вакцина &#34;овикон&#34; против инфекционных заболеваний конечностей овец
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO, ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.